Perbedaan Organon Pharma Indonesia Tbk. dan Solusi Sinergi Digital Tbk.: Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M), sedangkan Solusi Sinergi Digital Tbk. diperdagangkan di Rp1.995 (kapitalisasi pasar 10,88 T, volume 24 jam 24,13 jt). Perbedaan utamanya: Solusi Sinergi Digital Tbk. jauh lebih besar — sekitar 104,2× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| SCPI | WIFI | |
|---|---|---|
Kapitalisasi Pasar | 104,4 M | 10,88 T |
Volume | — | 24,13 jt |
Lot | — | 241,31 rb |
Perputaran | — | 48,25 M |
Harga Rata-rata | — | 1.999,27 |
Nilai Transaksi | — | 48,25 M |
Harga Ekuilibrium Indikatif | — | 1.995 |
Volume Ekuilibrium Indikatif | — | 11,93 rb |
Imbal hasil berjalan pada periode standar
Berita terbaru kedua aset
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →PT Solusi Sinergi Digital Tbk (the Company) was established based on Notarial Deed No. 21 of Humberg Lie, S.H., S.E., M.Kn dated September 6, 2012. The Company begin their operation activities in 2012.
Selengkapnya di halaman WIFI →